These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 24229753)
1. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. Deligiannidis KM; Rothschild AJ; Barton BA; Kroll-Desrosiers AR; Meyers BS; Flint AJ; Whyte EM; Mulsant BH; J Clin Psychiatry; 2013 Oct; 74(10):1003-9. PubMed ID: 24229753 [TBL] [Abstract][Full Text] [Related]
2. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression. Bingham KS; Rothschild AJ; Mulsant BH; Whyte EM; Meyers BS; Banerjee S; Szanto K; Flint AJ; J Clin Psychiatry; 2017; 78(8):1149-1154. PubMed ID: 28445632 [TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Meyers BS; Flint AJ; Rothschild AJ; Mulsant BH; Whyte EM; Peasley-Miklus C; Papademetriou E; Leon AC; Heo M; Arch Gen Psychiatry; 2009 Aug; 66(8):838-47. PubMed ID: 19652123 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Weissman J; Flint A; Meyers B; Ghosh S; Mulsant B; Rothschild A; Whyte E; Psychiatry Res; 2012 May; 197(3):221-6. PubMed ID: 22464991 [TBL] [Abstract][Full Text] [Related]
5. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Alexopoulos GS; Rudorfer MV; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Mulsant BH; JAMA; 2019 Aug; 322(7):622-631. PubMed ID: 31429896 [TBL] [Abstract][Full Text] [Related]
6. Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account. Østergaard SD; Meyers BS; Flint AJ; Mulsant BH; Whyte EM; Ulbricht CM; Bech P; Rothschild AJ; J Affect Disord; 2014 May; 160():68-73. PubMed ID: 24439830 [TBL] [Abstract][Full Text] [Related]
7. Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study. Flint AJ; Rothschild AJ; Whyte EM; Alexopoulos GS; Mulsant BH; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Meyers BS; Am J Geriatr Psychiatry; 2021 Jul; 29(7):645-654. PubMed ID: 33268022 [TBL] [Abstract][Full Text] [Related]